Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 54 | 0 | 5 | 0 | €110.95 | €148.44 | 33.789% |
| Insulet Corp. | 54 | 0 | 4 | 0 | €170.90 | €315.34 | 84.515% |
| Ionis Pharmaceuticals Inc. | 51 | 1 | 4 | 0 | €63.74 | €77.41 | 21.445% |
| Tenet Healthcare | 47 | 0 | 0 | 0 | €164.00 | €193.52 | 18.002% |
| Alnylam Pharmace. | 46 | 0 | 3 | 0 | €287.80 | €428.30 | 48.818% |
| Jazz Pharmaceuticals plc | 35 | 0 | 1 | 0 | €170.50 | €176.91 | 3.760% |
| Acadia Pharmaceuticals | 34 | 1 | 1 | 0 | €18.67 | €28.15 | 50.789% |
| United Therapeutics | 32 | 1 | 4 | 0 | €490.70 | €507.66 | 3.456% |
| Exelixis Inc. | 30 | 1 | 0 | 0 | €38.90 | €42.21 | 8.533% |
| Merit Medical Systems | 27 | 0 | 3 | 0 | ? | €90.95 | 52.850% |
| PTC Therapeutics Inc. | 28 | 1 | 1 | 0 | ? | €67.74 | 14.662% |
| Ultragenyx Pharmaceutical Inc. | 24 | 0 | 0 | 0 | ? | €55.67 | 179.735% |
| Charles River Labs Intl | 23 | 0 | 1 | 0 | €152.10 | €165.88 | 9.058% |
| Bio-Techne Corp. | 21 | 0 | 1 | 0 | €47.38 | €60.82 | 28.373% |
| Haemonetics Corp. | 21 | 0 | 1 | 0 | €51.50 | €75.91 | 47.404% |
| Arrowhead Pharmaceuticals Inc. | 21 | 0 | 1 | 0 | €56.54 | €69.18 | 22.351% |
| Halozyme Therapeutics Inc. | 19 | 2 | 0 | 0 | €57.08 | €70.40 | 23.341% |
| Alkermes plc | 17 | 0 | 1 | 0 | ? | €37.89 | 33.420% |
| Iovance Biotherapeutics Inc. | 18 | 2 | 2 | 0 | €3.10 | €10.67 | 244.708% |
| Agios Pharmaceuticals Inc. | 15 | 0 | 0 | 0 | €28.20 | €36.75 | 30.337% |
| Bruker Corp. | 15 | 1 | 2 | 0 | €33.84 | €43.34 | 28.059% |
| Icon plc | 13 | 0 | 2 | 0 | €95.84 | €191.52 | 99.833% |
| Xencor Inc. | 15 | 2 | 0 | 0 | ? | €22.44 | 120.031% |
| Masimo Corp. | 12 | 0 | 0 | 0 | €152.00 | €171.48 | 12.816% |
| West Pharmaceutical Services Inc. | 12 | 0 | 0 | 0 | €227.20 | €297.60 | 30.988% |